[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-371869-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-371869-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","hederin-inhibits-cervical-cancer-progression-by-inducing-dna-damage-dependent-cell-cycle-blockade-and-apoptosis","α-hederin inhibits cervical cancer progression by inducing DNA damage-dependent cell cycle blockade and apoptosis","","Background Cervical cancer incidence has not decreased significantly despite widespread use of HPV vaccines and screening measures. This study explored α-Hederin as a potential therapy for cervical cancer. Methods assessed apoptosis, cell cycle, ROS, and mitochondrial membrane potential using assays including CCK8, EdU staining, and flow cytometry, supported by transcriptome and single-cell sequencing, protein validation, in vivo tumorigenicity in nude mice, and metabolomics. Results showed strong inhibition of proliferation, migration, invasion, and G2M arrest with DNA damage–linked pathway regulation, alongside enhanced apoptosis and tumor growth suppression in vivo.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/hederin-inhibits-cervical-cancer-progression-by-inducing-dna-damage-dependent-cell-cycle-blockade-and-apoptosis/371869/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/hederin-inhibits-cervical-cancer-progression-by-inducing-dna-damage-dependent-cell-cycle-blockade-and-apoptosis/371869.png","ImageObject",300,407,{"name":42,"@type":43},"Bulrr","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-02","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the purpose of this study on α-hederin?","Question",{"text":63,"@type":64},"To explore the potential of α-Hederin in the treatment of cervical cancer.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which experimental approaches were used to assess α-hederin’s effects?",{"text":68,"@type":64},"The study used CCK8, EdU staining, flow cytometry for apoptosis/cell cycle and related endpoints, along with transcriptome sequencing, bioinformatics, single-cell sequencing, protein assays (e.g., western blot and immunofluorescence), and in vivo nude mouse tumorigenicity with metabolomics.",{"name":70,"@type":61,"acceptedAnswer":71},"How does α-hederin affect the cervical cancer cell cycle and signaling?",{"text":72,"@type":64},"It inhibits the G2M phase by suppressing CDK1 and CyclinB expression and is proposed to regulate activity via ATM–CHK1–CDC25B/CDC25C and ATM–P53–P21 pathways linked to DNA damage.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},371869,1790224658,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},5909892115043,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Song et al. BMC Cancer (2025) 25:1503 BMC Cancer  \n[https://doi.org/10.1186/s12885-025-14920-4](https://doi.org/10.1186/s12885-025-14920-4)  \nRESEARCH Open Access  \nα-hederin inhibits cervical cancer progression by inducing DNA damage-dependent cell cycle blockade and apoptosis  \nYanlun Song 1,2,3†, Haimei Qin 1,2,3†, Shaofeng Huang3,5, Jian Wang 1,2,3, Yuehua Huang2,3,4, Zongyun Lin 1,2,3, Fenglian Yang3,5, Xin Zhang2,3,4, Rong Wang2,3,4* and Junli Wang 1,2,3*  \nAbstract  \nBackground Cervical cancer incidence has not decreased significantly despite widespread use of HPV vaccines and screening measures.  \nPurpose This study explored the potential of α-Hederin in the treatment of cervical cancer.  \nMethods CCK8, EdU staining assay, flow cytometry were conducted for apoptosis, cell cycle, ROS, and mitochondrial membrane potential. Mechanism effects of α-hederin on cervical cancer cells were investigated using transcriptome sequencing, bioinformatics analysis, and single-cell sequencing. Further in-depth detection of key proteins with western blot, immunofluorescence, overexpression of CHK1 gene, DNA damage inhibitors, and NAC inhibitors were performed to study the regulation of the cell cycle. In vivo nude mice tumorigenicity experiments and metabolomics analysis of the tumor tissue were also performed.  \nResults α-Hederin significantly inhibited SiHa and HeLa cell growth, promoted apoptosis, and inhibited migration and invasion of cervical cancer cells. Sequencing and bioinformatics analysis revealed that α-hederin mainly regulated cell cycle, DNA replication, P53, and other signaling pathways to inhibit the proliferation of cervical cancer cells and inhibited the G2M phase of the cell cycle, mainly by suppressing CDK1 and CyclinB expression. α-hederin may use ATM-CHK1-CDC25B/CDC25C and ATM-P53-P21 to regulate CDK1/Cycline B activity. Inhibition of this action significantly promoted G2M phase block. In vivo experiment indicated that the drug can effectively inhibit cervical cancer growth.  \nConclusion α-hederin may be an effective drug to inhibit cervical cancer and has a good development prospect. Keywords α-hederin, Cervical cancer, Cell cycle, DNA damage  \n†Yanlun Song and Haimei Qin contributed equally to this work.  \n*Correspondence:  \nRongWang [rongwang50@163.com](rongwang50@163.com)[ ](rongwang50@163.com)Junli Wang [13907768146@163.com](13907768146@163.com)  \n1Reproductive Medicine Center, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, Guangxi, China  \n2Key Laboratory of Research On Clinical Molecular Diagnosis for High Incidence Diseases in Western Guangxi of Guangxi Higher Education Institutions, Baise, China  \n3Modern Industrial College of Biomedicine and Great Health, Youjiang Medical University for Nationalities, Baise, Guangxi, China 4Department of Blood Transfusion, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, Guangxi, China  \n5School of Pharmacy, Youjiang Medical University for Nationalities, Baise, Guangxi, China  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder","cbCaiv0ZDHkAsbvb","https://ap.wps.com/l/cbCaiv0ZDHkAsbvb","pdf",9067544,25,"English","# Abstract\n# Introduction\n## Background and clinical challenge\n## Current therapies and resistance\n## Rationale for natural compounds and α-hederin\n# Methods (overview)\n## In vitro assays\n## Mechanistic investigation\n## In vivo and metabolomics","[{\"question\":\"What was the purpose of this study on α-hederin?\",\"answer\":\"To explore the potential of α-Hederin in the treatment of cervical cancer.\"},{\"question\":\"Which experimental approaches were used to assess α-hederin’s effects?\",\"answer\":\"The study used CCK8, EdU staining, flow cytometry for apoptosis/cell cycle and related endpoints, along with transcriptome sequencing, bioinformatics, single-cell sequencing, protein assays (e.g., western blot and immunofluorescence), and in vivo nude mouse tumorigenicity with metabolomics.\"},{\"question\":\"How does α-hederin affect the cervical cancer cell cycle and signaling?\",\"answer\":\"It inhibits the G2M phase by suppressing CDK1 and CyclinB expression and is proposed to regulate activity via ATM–CHK1–CDC25B/CDC25C and ATM–P53–P21 pathways linked to DNA damage.\"}]","α-hederin inhibits cervical cancer progression by inducing DNA damage-dependent cell cycle blockade and apoptosis | PDF",1790193064,63,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1dbe07985685bbad546601c042747478.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dd17aaedab9f6456842493ebbb352bcd.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e8c7abd17d37fc02e8cd78b819d4d7d9.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e19c44b7f5092f152a29d204f90648dd.webp",980,1306]